Identifying risk factors enables physicians to implement targeted intervention strategies and preventive measures, aiming to reduce the disease burden and minimize the risk of relapse. Multiple ...

Mendelian randomization revealed a significant link between higher genetically-determined BMI and increased MS severity, strengthening previous observational findings. Expanded analysis included ...

An international study has used a computational biology tool that, by analyzing a multitude of biological data from multiple sclerosis patients ranging from genetic information to the whole organism, ...

The CD40–CD40L costimulatory pathway regulates adaptive and innate immune responses and has been implicated in the pathogenesis of multiple sclerosis. Frexalimab is a second-generation anti-CD40L ...

Multiple myeloma (MM) is a highly heterogeneous, incurable disease most frequently diagnosed in the elderly. Therefore, data on clinical characteristics and outcomes in the very young population are ...

Daratumumab, a monoclonal antibody targeting CD38, has been approved for use with standard myeloma regimens. An evaluation of subcutaneous daratumumab combined with bortezomib, lenalidomide, and ...

An increase in Campylobacter and Salmonella infections in England has been attributed to multiple factors. It is estimated ...